CHIAVERINI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.280
AS - Asia 957
EU - Europa 511
SA - Sud America 124
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 24
OC - Oceania 2
Totale 2.983
Nazione #
US - Stati Uniti d'America 1.190
SG - Singapore 338
CN - Cina 257
IT - Italia 254
HK - Hong Kong 130
BR - Brasile 104
VN - Vietnam 74
CA - Canada 54
DE - Germania 51
FR - Francia 40
KR - Corea 40
FI - Finlandia 33
SE - Svezia 29
GB - Regno Unito 27
IN - India 27
PK - Pakistan 17
JP - Giappone 16
NL - Olanda 16
CI - Costa d'Avorio 11
PL - Polonia 10
CR - Costa Rica 9
IL - Israele 9
MX - Messico 9
CH - Svizzera 8
RU - Federazione Russa 8
AR - Argentina 7
ES - Italia 7
SA - Arabia Saudita 7
AT - Austria 6
TR - Turchia 6
UZ - Uzbekistan 6
IQ - Iraq 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
BD - Bangladesh 4
BE - Belgio 4
CZ - Repubblica Ceca 4
IE - Irlanda 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
PE - Perù 3
SN - Senegal 3
CL - Cile 2
EC - Ecuador 2
GT - Guatemala 2
ID - Indonesia 2
IR - Iran 2
JM - Giamaica 2
PH - Filippine 2
PR - Porto Rico 2
UA - Ucraina 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
CD - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GP - Guadalupe 1
JO - Giordania 1
KG - Kirghizistan 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.898
Città #
Singapore 217
Ashburn 200
San Jose 177
Hong Kong 129
Dallas 124
Hefei 68
Santa Clara 64
Los Angeles 51
Council Bluffs 44
Pisa 43
Milan 42
Seoul 40
Shanghai 28
Ho Chi Minh City 24
Munich 24
Helsinki 22
Beijing 21
Chandler 17
Boardman 16
Florence 16
Rome 16
Tokyo 16
Frankfurt am Main 15
Hanoi 15
Lucca 14
Livorno 13
London 13
New York 12
Abidjan 11
Baltimore 11
Columbus 11
Montreal 10
Redondo Beach 10
Karachi 9
Lauterbourg 9
San José 9
São Paulo 9
Toronto 9
Casciana Terme Lari 8
Figino 8
North Bergen 8
Zurich 8
Boston 7
Buffalo 7
Hyderabad 7
Kent 7
Lahore 7
Mexico City 7
Phoenix 7
San Giuliano Terme 7
Seattle 7
Turku 7
Warsaw 7
Chicago 6
Salt Lake City 6
Tashkent 6
Memphis 5
Ogden 5
Orem 5
Philadelphia 5
Poplar 5
Washington 5
Almaty 4
Amsterdam 4
Brno 4
Clarksville 4
Correggio 4
Denver 4
Dulles 4
Houston 4
Lappeenranta 4
Turin 4
Atlanta 3
Bologna 3
Bragança Paulista 3
Brasília 3
Brooklyn 3
Brussels 3
Chennai 3
Dakar 3
Danville 3
Fuzhou 3
Genoa 3
Hillsboro 3
Jeddah 3
Krakow 3
Madrid 3
Manchester 3
Miami 3
Rio de Janeiro 3
Saint Augustine 3
Uberlândia 3
Vienna 3
Albany 2
Alessandria 2
Allenwood Cross Roads 2
Blida 2
Brampton 2
Bremen 2
Calgary 2
Totale 1.853
Nome #
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 253
AS101: An overview on a leading tellurium-based prodrug 185
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues 185
FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo 174
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 171
Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational Changes 163
From conventional therapy to novel nano-based approaches. A focus on prostate cancer 158
Antimicrobial and Antibiofilm Activity of Auranofin and Its Two Derivatives Bearing Naproxen and Acetylcysteine as Ligands Against Staphylococci 155
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity 153
Non‐medical applications of inorganic medicines. A switch based on mechanistic knowledge 138
Dimolybdenum (II,II) paddlewheel complexes bearing non-steroidal anti-inflammatory drug ligands: Insights into the chemico-physical profile and first biological assessment 124
Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal properties 108
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity-a perspective overview 104
The binding of auranofin at DNA/RNA nucleobases: A DFT assessment 94
The metal(loid)s’ dilemma. What's the next step for a new era of inorganic molecules in medicine? 93
Is the Next Cisplatin Already in Our Laboratory? 90
Copper(II) binding properties and anticancer activity of peptide fragments from a β-strand region of angiogenin protein 75
Solution stability and storage effect on selected metallodrugs: a multi-technique evaluation 64
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes 64
The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells 59
Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy 57
Liquid chromatography-based metallomics and transmission electron microscopy reveal gold nanoparticle surface treatment with vicinal dithiols to abolish protein corona formation 53
Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexes 45
From simple to complex: multiscale modeling of metal-mediated protein interactions to uncover mechanistic insights into the action of inorganic drugs 41
null 41
Multifunctional auranofin analogues: dual-targeting TSPO/TrxR gold(I) complexes with activity in resistant ovarian cancer 39
A Dual-Action Gold(I) Prodrug Targeting Redox Homeostasis and Extracellular Matrix Remodeling in Ovarian Cancer 36
null 23
Tuning Au Reactivity Beyond Canonical Targets: Ligand-Driven Au(I) Metalation of Lysine Residues in Hen Egg White Lysozyme 22
Tailoring the biological activity of oxorhenium(V) complexes through Chrysin ligand functionalization 16
Totale 2.983
Categoria #
all - tutte 7.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 0 0 0 0 4 4
2022/202395 3 9 2 7 4 10 0 8 40 1 2 9
2023/2024148 3 4 8 12 27 10 16 11 4 2 28 23
2024/2025694 0 18 7 34 51 69 53 16 67 63 121 195
2025/20261.454 78 161 148 113 115 108 239 86 120 148 46 92
2026/2027584 59 82 131 290 22 0 0 0 0 0 0 0
Totale 2.983